Group B streptococcal infections in the newborn infant and the potential value of maternal vaccination

References

• Edwards MS, Nizet V, Group B. Streptococcal infections. In: Remington JS, Klein JO, editors. Infectious diseases of the fetus and newborn infant. 8th edition. Elsevier Saunders; Philadelphia: 2016. p. 411-56
   Google Scholar
• Centers for disease control and prevention. 2013. Active bacterial core surveillance (ABCs) report emerging infections program network group B streptococcus, 2013-provisional. Available from: www.cdc.gov/abcs/reports-findings/survreports/gbs13.pdf [Last accessed 3 April 2015]
   Google Scholar
• Schuchat A. Epidemiology of group B streptococcal disease in the US: shifting paradigms. Clin Microbiol Rev 1998;11:497-513
   PubMed Web of Science ®Google Scholar
• Phares CR, Lynfield R, Farley MM, et al. Active bacterial core surveillance/emerging infections program network. Epidemiology of invasive group B streptococcal dis- ease in the US, 1999-2005. J Am Med Assoc 2008;299:2056-65
   PubMed Web of Science ®Google Scholar
• Regan JA, Klebanoff MA, Nugent RP, et al. Colonization with group B streptococci in pregnancy and adverse outcome. VIP Study Group. Am J Obstet Gynecol 1996;174:1354-60
   PubMed Web of Science ®Google Scholar
• Melin P, Efstratiou A. Group B streptococcal epidemiology and vaccine needs in developed countries. Vaccine 2013;28:31-42
   Web of Science ®Google Scholar
• Yancey MK, Schichat A, Brown LK, et al. The accuracy of late antenatal screening cultures in prediciting genital group B streptococcal colonization at delivery. Obstet Gynecol 1996;88:811-15
   PubMed Web of Science ®Google Scholar
• Edwards RK, Clark P, Duff P. Intrapartum antibiotic prophylaxis 2: positive predictive value of antenatal group B streptococci cultures and antibiotic susceptibility of clinical isolates. Obstet Gynecol 2002;100:540-4
   PubMed Web of Science ®Google Scholar
• Valkenburg-van den Berg AW, Sprij AJ, Oostvogel PM, et al. Prevalence of colonisation with group B streptococci in pregnant women of a multiethnic population in The Netherlands. Eur J Obstet Gynecol Reprod Biol 2006;124:178-83
   PubMed Web of Science ®Google Scholar
• El Helali N, Nguyen JC, Ly A, et al. Diagnostic accuracy of a rapid real-time polymerase chain reaction assay for universal intrapartum group B streptococcus screening. Clin Infect Dis 2009;49:417-23
   PubMed Web of Science ®Google Scholar
• Puopolo KM, Madoff LC, Eichenwald EC. Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics 2005;115:1240-6
   PubMed Web of Science ®Google Scholar
• Pulver LS, Hopfenbeck MM, Young PC, et al. Continued early onset group B streptococcal infections in the era of intrapartum prophylaxis. J Perinatol 2009;29:20-5
   PubMed Web of Science ®Google Scholar
• Stoll BJ, Hansen NI, Sánchez PJ, et al. Early onset neonatal sepsis: the burden of group B streptococcal and E. coli disease continues. Pediatrics 2011;127:817-26
   PubMed Web of Science ®Google Scholar
• Berardi A, Lugli L, Rossi C, et al. Impact of perinatal practices for early-onset group-B streptococcal disease prevention. Pediatr Infect Dis J 2013;32:265-71
   PubMed Web of Science ®Google Scholar
• El Helali N, Giovangrandi Y, Guyot K, et al. Cost and effectiveness of intrapartum group B streptococcus polymerase chain reaction screening for term deliveries. Obstet Gynecol 2012;119:822-9
   PubMed Web of Science ®Google Scholar
• Berardi A, Rossi C, Guidotti I, et al. Factors associated with intrapartum transmission of group B streptococcus. Pediatr Infect Dis J 2014;33:1211-15
   PubMed Web of Science ®Google Scholar
• Bergeron MG, Danbing K. New DNA-based PCR approaches for rapid real-time detection and prevention of group B streptococcal infections in newborns and pregnant women. Reprod Medi Rev 2004;11:25-41
   Google Scholar
• Di Renzo GC, Melin P, Berardi A, et al. Intrapartum GBS screening and antibiotic prophylaxis: a European consensus conference. J Matern Fetal Neonatal Med 2014;27:1-17
   Google Scholar
• Edmond KM, Kortsalioudaki C, Scott S, et al. Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet 2012;379:547-56
   PubMed Web of Science ®Google Scholar
• Springman AC, Lacher DW, Wu G, et al. Selection, recombination, and virulence gene diversity among group B streptococcal genotypes. J Bacteriol 2009;191:5419-27
   PubMed Web of Science ®Google Scholar
• Sørensen UB, Poulsen K, Ghezzo C, et al. Emergence and global dissemination of host-specific Streptococcus agalactiae clones. MBio 2010;1:e00178-10
   Web of Science ®Google Scholar
• Da Cunha V, Davies MR, Douarre PE, et al. Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline. Nat Commun 2014;5:4544
   PubMed Web of Science ®Google Scholar
• Landwehr-Kenzel S, Henneke P. Interaction of streptococcus agalactiae and cellular innate immunity in colonization and disease. Front Immunol 2014;5:519
   PubMed Web of Science ®Google Scholar
• Tazi A, Disson O, Bellais S, et al. The surface protein HvgA mediates Group B streptococcus hypervirulence and meningeal tropism in neonates. J ExpMed 2010;207:2313-22
   Web of Science ®Google Scholar
• Berner R, Niemeyer CM, Leititis JU, et al. Plasma levels and gene-expression of G-CSF, TNF-alpha, IL-1beta, IL-6, IL-8, and sICAM-1 in neonatal early-onset sepsis. Pediatr Res 1998;44:469-77
   PubMed Web of Science ®Google Scholar
• Berner R. Significance, management and prevention of Streptococcus agalactiae infection during the perinatal period. Expert Rev Anti Infect Ther 2004;2:427-37
   PubMedGoogle Scholar
• Fujieda M, Aoyagi Y, Matsubara K, et al. L-ficolin and capsular polysaccharide-specific IgG in cord serum contribute synergistically to opsonophagocytic killing of serotype III and V group B streptococci. Infect Immun 2012;80:2053-60
   PubMed Web of Science ®Google Scholar
• Benitz WE, Gould JB, Druzin ML. Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review. Pediatrics 1999;103:77
   PubMed Web of Science ®Google Scholar
• Verani JR, McGee L, Schrag SJ. Prevention of perinatal group B Streptococcal disease. Revised guidelines from CDC. 2010. MMWR Recomm Rep 2010;59:1-36
   PubMedGoogle Scholar
• Heath PT, Balfour G, Weisner AM, et al. Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet 2004;363:292-4
   PubMed Web of Science ®Google Scholar
• Antony BF, Okada DM, Hobel CJ. Epidemiology of the group B streptococcus: Maternal and nosocomial sources for infant acquisitions. J Pediatr 1979;95(3):431-6
   PubMed Web of Science ®Google Scholar
• Royal college of obstetricians and gynaecologists: Guidelines. The prevention of early onset neonatal group B streptococcal disease. Green-top Guideline N 36. 2nd Edition. Available from: www.rcog.org.uk/files/rcogcorp/GTG36_GBS.pdf [Last accessed 1–13 July 2012]
   Google Scholar
• Bromberger P, Lawrence JM, Braun D, et al. The influence of intrapartum antibiotics on the clinical spectrum of early-onset group B streptococcal infection in term infants. Pediatrics 2000;106:244-50
   PubMed Web of Science ®Google Scholar
• Berardi A, Lugli L, Rossi C, et al. Intrapartum antibiotic prophylaxis failure and group-B streptococcus early-onset disease. J Matern Fetal Neonatal Med 2011;24:1221-4
   PubMed Web of Science ®Google Scholar
• Mc Cracken GHJr. Group B streptococci: the new challenge in neonatal infections. J Pediatr 1973;82:703-6
   PubMed Web of Science ®Google Scholar
• Berardi A, Rossi C, Lugli L, et al. Group B Streptococcus late-onset disease: 2003–2010. Pediatrics 2013;131:361-8
   PubMed Web of Science ®Google Scholar
• Paredes A, Wong P, Mason EOJr, et al. Nosocomial transmission of group B Streptococci in a newborn nursery. Pediatrics 1977;59:679-82
   PubMed Web of Science ®Google Scholar
• Barbadoro P, Marigliano A, Savini S, et al. Group B Streptococcal sepsis: an old or ongoing threat? Am J Infect Control 2011;39:45-8
   Web of Science ®Google Scholar
• Filleron A, Lombard F, Jacquot A, et al. Group B streptococci in milk and late neonatal infections: an analysis of cases in the literature. Arch Dis Child Fetal Neonatal Ed 2014;99:41-7
   Google Scholar
• Berardi A, Rossi C, Creti R, et al. Group B streptococcal colonization in 160 mother-baby pairs: a prospective cohort study. J Pediatr 2013;163:1099-104
   PubMed Web of Science ®Google Scholar
• Lin FY, Weisman LE, Troendle J, et al. Prematurity is the major risk factor for late-onset group B streptococcus disease. J Infect Dis 2003;188:267-71
   PubMed Web of Science ®Google Scholar
• Lanari M, Serra L, Cavrini F, et al. Late-onset group B streptococcal disease by infected mother’s milk detected by polymerase chain reaction. New Microbiol 2007;30:253-4
   PubMed Web of Science ®Google Scholar
• Fluegge K, Greiner P, Berner R. Late onset group B streptococcal disease manifested by isolated cervical lymphadenitis. Arch Dis Child 2003;88:1019-20
   PubMed Web of Science ®Google Scholar
• Jordan HT, Farley MM, Craig A, et al. Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis. Pediatr Infect Dis J 2008;27:1057-64
   PubMed Web of Science ®Google Scholar
• Peña BM, Harper MB, Fleisher GR. Occult bacteremia with group B streptococci in an outpatient setting. Pediatrics 1998;102:67-72
   PubMed Web of Science ®Google Scholar
• Fluegge K, Siedler A, Heinrich B, et al. Incidence and clinical presentation of invasive neonatal group B streptococcal infections in Germany. Pediatrics 2006;117:1139-45
   Web of Science ®Google Scholar
• Libster R, Edwards KM, Levent F, et al. Long-term outcomes of group B streptococcal meningitis. Pediatrics 2012;130:8-15
   PubMed Web of Science ®Google Scholar
• Ohlsson A, Shah VS. Intrapartum antibiotics for known maternal Group B streptococcal colonization. Cochrane Database Syst Rev 2013;1:CD007467
   PubMedGoogle Scholar
• Rodriguez-Granger J, Alvargonzalez JC, Berardi A, et al. Prevention of group B streptococcal neonatal disease revisited. The DEVANI European project. Eur J Clin Microbiol Infect Dis 2012;31:2097-104
   PubMed Web of Science ®Google Scholar
• Schrag SJ, Zell ER, Lynfield R, et al. A population-based comparison of strategies to prevent early onset group B streptococcal disease in neonates. N Engl J Med 2002;347:233-9
   PubMed Web of Science ®Google Scholar
• Bekker V, Bijlsma MW, van de Beek D, et al. Incidence of invasive group B streptococcal disease and pathogen genotype distribution in newborn babies in the Netherlands over 25 years: a nationwide surveillance study. Lancet Infect Dis 2014;14:1083-9
   PubMed Web of Science ®Google Scholar
• Lamagni TL, Keshishian C, Efstratiou A, et al. Emerging trends in the epidemiology of invasive group B streptococcal disease in England and Wales, 1991-2010. Clin Infect Dis 2013;57:682-8
   PubMed Web of Science ®Google Scholar
• Berardi A, Lugli L, Baronciani D, et al. GBS Prevention working group of Emilia-Romagna. Group B streptococcus early-onset disease in Emilia-Romagna: review after introduction of a screening-based approach. Pediatr Infect Dis J 2010;29:115-21
   PubMed Web of Science ®Google Scholar
• Brady MT, Polin RA. Prevention and management of infants with suspected or proven neonatal sepsis. Pediatrics 2013;132:166-8
   PubMed Web of Science ®Google Scholar
• Benitz WE, Wynn JL, Polin RA. Reappraisal of guidelines for management of neonates with suspected early-onset sepsis. J Pediatr 2015;166:1070-4
   PubMed Web of Science ®Google Scholar
• Ottolini MC, Lundgren K, Mirkinson LJ, et al. Utility of complete blood count and blood culture screening to diagnose neonatal sepsis in the asymptomatic at risk newborn. Pediatr Infect Dis J 2003;22:430-4
   PubMed Web of Science ®Google Scholar
• Glasgow TS, Speakman M, Firth S, et al. Clinical and economic outcomes for term infants associated with increasing administration of antibiotics to their mothers. Paediatr Perinat Epidemiol 2007;21:338-46
   PubMed Web of Science ®Google Scholar
• Flidel-Rimon O, Galstyan S, Juster-Reicher A, et al. Limitations of the risk factor based approach in early neonatal sepsis evaluations. Acta Paediatr 2012;101:540-4
   PubMed Web of Science ®Google Scholar
• National institute for health and clinical excellence. Antibiotics for early-onset neonatal infection: antibiotics for the prevention and treatment of early-onset neonatal infection. (CG102). London: NICE; 2012. Available from: http://guidance.nice.org.uk/CG149/Guidance/pdf/English [Last accessed 13 September 2013]
   Google Scholar
• Mukhopadhyay S, Eichenwald EC, Puopolo KM. Neonatal early-onset sepsis evaluations among well-appearing infants: projected impact of changes in CDC GBS guidelines. J Perinatol 2013;33:198-205
   PubMed Web of Science ®Google Scholar
• Escobar GJ, Li DK, Armstrong MA, et al. Neonatal sepsis workups in infants >/=2000 grams at birth: A population-based study. Pediatrics 2000;106:256-63
   PubMed Web of Science ®Google Scholar
• Cantoni L, Ronfani L, Da Riol R, et al. Physical examination instead of laboratory tests for most infants born to mothers colonized with group B Streptococcus: support for the Centers for Disease Control and Prevention’s 2010 recommendations. J Pediatr 2013;163:568-73
   PubMed Web of Science ®Google Scholar
• Berardi A, Fornaciari S, Rossi C, et al. Safety of physical examination alone for managing well-appearing neonates ≥35 weeks’ gestation at risk for early-onset sepsis. J Matern Fetal Neonatal Med 2014;10:1-5
   Google Scholar
• Dahesh S, Hensler ME, Van Sorge NM, et al. Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics. Antimicrob Agents Chemother 2008;52:2915-18
   PubMed Web of Science ®Google Scholar
• Kimura K, Suzuki S, Wachino J, et al. First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob Agents Chemother 2008;52:2890-7
   PubMed Web of Science ®Google Scholar
• Wang P, Tong JJ, Ma XH, et al. Serotypes, Antibiotic Susceptibilities, and multi-locus sequence type profiles of streptococcus agalactiae isolates circulating in Beijing, China. PLoS One 2015;10:e0120035
   PubMed Web of Science ®Google Scholar
• Imperi M, Gherardi G, Berardi A, et al. Invasive neonatal GBS infections from an area-based surveillance study in Italy. Clin Microbiol Infect 2011;17:1834-9
   PubMed Web of Science ®Google Scholar
• Mercer BM, Carr TL, Beazley DD, et al. Antibiotic use in pregnancy and drug-resistant infant sepsis. Am J Obstet Gynecol 1999;181:816-21
   PubMed Web of Science ®Google Scholar
• Schrag SJ, Hadler JL, Arnold KE, et al. Risk factors for invasive, early-onset Escherichia coli infections in the era of widespread intrapartum antibiotic use. Pediatrics 2006;118:570-6
   PubMed Web of Science ®Google Scholar
• Al-Hasan MN, Lahr BD, Eckel-Passow JE, et al. Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998–2007. J Antimicrob Chemother 2009;64:169-74
   PubMed Web of Science ®Google Scholar
• Penders J, Thijs C, Vink C, et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 2006;118:511-21
   PubMed Web of Science ®Google Scholar
• Sarkar S, Bhagat I, Hieber S, et al. Can neutrophil responses in very low birth weight infants predict the organisms responsible for late-onset bacterial or fungal sepsis? J Perinatol 2006;26:501-5
   PubMed Web of Science ®Google Scholar
• Deshmukh HS, Liu Y, Menkiti OR, et al. The microbiota regulates neutrophil homeostasis and host resistance to Escherichia coli K1 sepsis in neonatal mice. Nat Med 2014;20:524-30
   PubMed Web of Science ®Google Scholar
• Kuppala VS, Meinzen-Derr J, Morrow AL, et al. Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants. J Pediatr 2011;159(5):720-5
   PubMed Web of Science ®Google Scholar
• Shakib JH, Korgenski K, Sheng X, et al. Tetanus, diphtheria, acellular pertussis vaccine during pregnancy: pregnancy and infant health outcomes. J Pediatr 2013;163:1422-6
   PubMed Web of Science ®Google Scholar
• Munoz FM, Ferrieri P. Group B streptococcus vaccination in pregnancy: Moving toward a global maternal immunization program. Vaccine 2013;31:46-51
   Web of Science ®Google Scholar
• Rasmussen SA, Watson AK, Kennedy ED, et al. Vaccines and pregnancy: Past, present, and future. Semin Fetal Neonatal Med 2014;19:161
   PubMed Web of Science ®Google Scholar
• Omer SB, Goodman D, Steinhoff MC, et al. Maternal influenza immunization and reduced likelihood of prematurity and small for gestational age births: a retrospective cohort study. PLoS Med 2011;8(5):e1000441
   PubMed Web of Science ®Google Scholar
• Zaman K, Roy E, Arifeen SE, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008;359:1555-64
   PubMed Web of Science ®Google Scholar
• Amirthalingam G, Andrews N, Campbell H, et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet 2014;384:1521-8
   PubMed Web of Science ®Google Scholar
• Mc Quaid F, Jones C, Stevens Z, et al. Attitudes towards vaccination against group B streptococcus in pregnancy. Arch Dis Child 2014;99:700-1
   PubMed Web of Science ®Google Scholar
• Dempsey AF, Pyrzanowski J, Donnelly M, et al. Acceptability of a hypothetical group B strep vaccine among pregnant and recently delivered women. Vaccine 2014;32:2463-8
   PubMed Web of Science ®Google Scholar
• Rubens CE, Wessels MR, Heggen LM, et al. Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence. Proc Natl Acad Sci USA 1987;84:7208-12
   PubMed Web of Science ®Google Scholar
• Baker CJ, Kasper L. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med 1976;294:753-6
   PubMed Web of Science ®Google Scholar
• Baker CJ, Kasper DL, Tager IRAB et al. Quantitative determination of antibody to capsular polysaccharide in infection with type III strains of group B streptococcus. J Clin Invest 1977;59:810-18
   PubMed Web of Science ®Google Scholar
• Baker CJ, Edwards MS, Kasper DL. Role of antibody to native type III polysaccharide of group B streptococcus in infant infection. Pediatrics 1981;68:544-9
   PubMed Web of Science ®Google Scholar
• Lin FY, Weisman LE, Azimi PH, et al. Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen. J Infect Dis 2004;190:928-34
   PubMed Web of Science ®Google Scholar
• Baker CJ, Paoletti LC, Wessels MR, et al. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. J Infect Dis 1999;179:142-50
   PubMed Web of Science ®Google Scholar
• Baker CJ, Rench MA, Fernandez M, et al. Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III. J Infect Dis 2003;188:66-73
   PubMed Web of Science ®Google Scholar
• Baker CJ, Paoletti LC, Rench MA, et al. Immune response of healthy women to two different type V group B streptococcal capsular polysaccharide-protein conjugate vaccines. J Infect Dis 2004;189:1103-12
   PubMed Web of Science ®Google Scholar
• Baker CJ, Carey VJ, Rench MA, et al. Maternal antibody at delivery protects neonates from early onset group B streptococcal disease. J Infect Dis 2014;209:781-8
   PubMed Web of Science ®Google Scholar
• Kasper DL, Paoletti LC, Wessels MR, et al. Immune response to type III group B Streptococcal polysaccharide–tetanus toxoid conjugate vaccine. J Clin Invest 1996;98:2308-14
   PubMed Web of Science ®Google Scholar
• Oster G, Edelsberga J, Hennegana K, et al. Prevention of group B streptococcal disease in the first 3 months of life: Would routine maternal immunization during pregnancy be cost-effective? Vaccine 2014;32:4778-85
   PubMed Web of Science ®Google Scholar
• Slobod K. Communication at XIX Lancefield International Symposium 9-12 November 2014 Buenos Aires, Argentina
   Google Scholar
• Madhi SA, Dangor Z, Heath PT, et al. Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants. Vaccine 2013;31:52-7
   PubMed Web of Science ®Google Scholar
• Larsson C, Holmgren J, Lindahl G, et al. Intranasal immunization of mice with group B streptococcal protein rib and cholera toxin B subunit confers protection against lethal infection. Infect Immun 2004;72(2):1184-7
   PubMed Web of Science ®Google Scholar
• Martin D, Rioux S, Gagnon E, et al. Protection from group B streptococcal infection in neonatal mice by maternal immunization with recombinant Sip protein. Infect Immun 2002;70:4897-901
   PubMed Web of Science ®Google Scholar
• Cheng Q, Debol S, Lam H, et al. Immunization with C5a peptidase or peptidase-type III polysaccharide conjugate vaccines enhances clearance of group B streptococci from lungs of infected mice. Infect Immun 2002;70:6409-15
   PubMed Web of Science ®Google Scholar
• Maione D, Margarit I, Rinaudo C.D, et al. Identification of a universal group B Streptococcus vaccine by multiple genome screen. Science 2005;309:148-50
   PubMed Web of Science ®Google Scholar
• Lauer P, Rinaudo C.D, Soriani M, et al. Genome analysis reveals pili in Group B Streptococcus. Science 2005;309:105
   PubMed Web of Science ®Google Scholar
• Rosini R, Rinaudo C.D, Soriani M, et al. Identification of novel genomic islands coding for antigenic pilus-like structures in Streptococcus agalactiae. Mol Microbiol 2006;61:126-41
   PubMed Web of Science ®Google Scholar
• Telford J.L, Barocchi M.A, Margarit I, et al. Pili in Gram-positive pathogens. Nat Rev Microbiol 2006;4:509-19
   PubMed Web of Science ®Google Scholar
• Margarit I, Rinaudo CD, Galeotti CL, et al. Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm. J Infect Dis 2009;199:108-15
   PubMed Web of Science ®Google Scholar
• Nuccitelli A, Cozzi R, Gourlay LJ, et al. Structure-based approach to rationally design a chimeric protein for an effective vaccine against Group B Streptococcus infections. Proc Natl Acad Sci USA 2011;108:10278-83
   PubMed Web of Science ®Google Scholar
• Kreikemeyer B, Gamez G, Margarit I, et al. Genomic organization, structure, regulation and pathogenic role of pilus constituents in major pathogenic streptococci and enterococci. Int J Med Microbiol 2011;30:240-51
   Web of Science ®Google Scholar
• Nilo A, Morelli L, Passalacqua I, et al. Anti-Group B Streptococcus Glycan-Conjugate Vaccines Using Pilus Protein GBS80 As Carrier and Antigen: Comparing Lysine and Tyrosine-directed Conjugation. ACS Chem Biol 2015. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Weston EJ, Pondo T, Lewis MM, et al. The burden of invasive early-onset neonatal sepsis in the US, 2005-2008. Pediatr Infect Dis J 2011;30:937-41
   PubMed Web of Science ®Google Scholar